CNS Pharmaceuticals, Inc. Rings the Opening Bell

ABOUT THIS EVENT

CNS Pharmaceuticals, Inc. (Nasdaq: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, visited the Nasdaq MarketSite in Times Square.

In honor of the occasion, John Climaco, CEO, rang the Opening Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore